A detailed history of Quadrant Capital Group LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 6,003 shares of ZTS stock, worth $1.05 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
6,003
Previous 5,974 0.49%
Holding current value
$1.05 Million
Previous $1.04 Million 13.24%
% of portfolio
0.08%
Previous 0.08%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$172.58 - $196.48 $5,004 - $5,697
29 Added 0.49%
6,003 $1.17 Million
Q2 2024

Aug 12, 2024

BUY
$145.54 - $178.83 $64,619 - $79,400
444 Added 8.03%
5,974 $1.04 Million
Q1 2024

May 15, 2024

SELL
$165.67 - $199.94 $72,894 - $87,973
-440 Reduced 7.37%
5,530 $935,000
Q4 2023

Feb 08, 2024

BUY
$151.44 - $200.09 $23,473 - $31,013
155 Added 2.67%
5,970 $1.18 Million
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $50,141 - $57,831
300 Added 5.44%
5,815 $1.01 Million
Q2 2023

Aug 09, 2023

SELL
$160.94 - $186.23 $11,909 - $13,781
-74 Reduced 1.32%
5,515 $949,000
Q1 2023

May 11, 2023

BUY
$145.48 - $175.02 $136,314 - $163,993
937 Added 20.14%
5,589 $930,000
Q4 2022

Feb 10, 2023

SELL
$131.14 - $157.47 $24,129 - $28,974
-184 Reduced 3.8%
4,652 $681,000
Q3 2022

Nov 10, 2022

SELL
$148.29 - $182.55 $39,741 - $48,923
-268 Reduced 5.25%
4,836 $717,000
Q2 2022

Aug 09, 2022

BUY
$155.97 - $200.09 $78,608 - $100,845
504 Added 10.96%
5,104 $877,000
Q1 2022

May 06, 2022

SELL
$181.39 - $234.03 $14,511 - $18,722
-80 Reduced 1.71%
4,600 $867,000
Q4 2021

Feb 01, 2022

BUY
$193.69 - $247.03 $14,139 - $18,033
73 Added 1.58%
4,680 $1.14 Million
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $6,625 - $7,339
-35 Reduced 0.75%
4,607 $894,000
Q2 2021

Aug 09, 2021

SELL
$155.9 - $187.99 $34,142 - $41,169
-219 Reduced 4.51%
4,642 $865,000
Q1 2021

May 12, 2021

BUY
$144.0 - $169.39 $32,112 - $37,773
223 Added 4.81%
4,861 $766,000
Q4 2020

Feb 16, 2021

BUY
$157.07 - $174.35 $4,555 - $5,056
29 Added 0.63%
4,638 $768,000
Q3 2020

Nov 13, 2020

SELL
$137.1 - $165.37 $124,349 - $149,990
-907 Reduced 16.44%
4,609 $762,000
Q2 2020

Aug 13, 2020

SELL
$111.92 - $142.53 $230,890 - $294,039
-2,063 Reduced 27.22%
5,516 $756,000
Q1 2020

May 15, 2020

BUY
$92.66 - $144.94 $200,330 - $313,360
2,162 Added 39.91%
7,579 $894,000
Q4 2019

Feb 03, 2020

BUY
$116.25 - $133.25 $47,546 - $54,499
409 Added 8.17%
5,417 $695,000
Q3 2019

Oct 24, 2019

BUY
$112.57 - $128.43 $23,977 - $27,355
213 Added 4.44%
5,008 $612,000
Q1 2019

Apr 29, 2019

BUY
$81.56 - $100.67 $11,663 - $14,395
143 Added 3.07%
4,795 $472,000
Q4 2018

Jan 17, 2019

BUY
$79.28 - $95.27 $262,654 - $315,629
3,313 Added 247.42%
4,652 $388,000
Q2 2018

Aug 09, 2018

BUY
$79.9 - $89.2 $3,675 - $4,103
46 Added 3.56%
1,339 $103,000
Q1 2018

May 10, 2018

SELL
$71.51 - $84.69 $89,673 - $106,201
-1,254 Closed
0 $0
Q3 2017

Oct 13, 2017

BUY
$59.73 - $65.4 $5,136 - $5,624
86 Added 7.36%
1,254 $71,000
Q2 2017

Aug 15, 2017

BUY
N/A
1,168
1,168 $50,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.